share_log

Agile Therapeutics's Earnings: A Preview

Agile Therapeutics's Earnings: A Preview

敏捷疗法的收益:预览
Benzinga ·  03/21 10:00

Agile Therapeutics (NASDAQ:AGRX) is set to give its latest quarterly earnings report on Friday, 2024-03-22. Here's what investors need to know before the announcement.

Agile Therapeutics(纳斯达克股票代码:AGRX)定于2024-03-22星期五发布其最新的季度收益报告。以下是投资者在宣布之前需要了解的内容。

Analysts estimate that Agile Therapeutics will report an earnings per share (EPS) of $-0.54.

分析师估计,敏捷疗法将公布的每股收益(EPS)为-0.54美元。

Agile Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

Agile Therapeutics的多头希望听到该公司宣布他们不仅超过了这一预期,而且还为下一季度提供积极的指导或预期的增长。

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

新投资者应注意,有时对股票价格影响最大的不是收益超过或失败,而是指导方针(或预测)。

Past Earnings Performance

过去的收益表现

Last quarter the company beat EPS by $0.37, which was followed by a 2.44% drop in the share price the next day.

上个季度,该公司每股收益高出0.37美元,随后第二天股价下跌2.44%。

Here's a look at Agile Therapeutics's past performance and the resulting price change:

以下是Agile Therapeutics过去的表现以及由此产生的价格变化:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -1.84 -3.48 -7.50 -11.5
EPS Actual -1.47 -3.10 -7.76 -9
Price Change % -2.0% -2.0% -12.0% -9.0%
季度 2023 年第三季度 2023 年第二季度 2023年第一季度 2022 年第四季度
每股收益估算 -1.84 -3.48 -7.50 -11.5
实际每股收益 -1.47 -3.10 -7.76 -9
价格变动% -2.0% -2.0% -12.0% -9.0%

eps graph

Stock Performance

股票表现

Shares of Agile Therapeutics were trading at $0.579 as of March 20. Over the last 52-week period, shares are down 95.04%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

截至3月20日,Agile Therapeutics的股票交易价格为0.579美元。在过去的52周中,股价下跌了95.04%。鉴于这些回报率通常为负数,长期股东可能会对本次财报感到不满。

To track all earnings releases for Agile Therapeutics visit their earnings calendar on our site.

要追踪Agile Therapeutics发布的所有财报,请访问我们网站上的财报日历。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成,并由编辑审阅。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发